Successfully navigating a drug development cycle is a major undertaking. On average, the sequence takes over a decade to ...

The CyBio FeliX, a benchtop instrument for automated liquid handling tasks, was used to automate the HaloPlex Target ...

The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...

Baidu CEO’s life sciences startup sees artificial intelligence ... is transforming fields like drug discovery by reducing ...

However, the biotech and pharmaceutical companies that develop these therapies do so at great expense. High drug development ...

Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, delivers life science ...

Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Stevanato Group (STVN – Research Report) yesterday and set a ...

He believes issues including rising obesity rates and declining life expectancy ... consultants and lobbyists cycle in and out of these agencies,” he said in August before adding: “A sick child is the ...

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in ...

insights and analytics for the life sciences industry, reveals that 50% of the 2023 U.S. pharmaceutical launch class ...

Stevanato Group Spa ( (STVN) ) has released its Q3 earnings. Here is a breakdown of the information Stevanato Group Spa presented to its ...